News

News-Medical.Net on MSN2d
One RSV shot cuts severe lung infections in older adults for three seasons, trial shows
A phase 3 trial involving nearly 25,000 older adults across 17 countries found that a single dose of the RSVPreF3 OA vaccine ...
McKnight's Long-Term Care News1d
RSV vaccine wanes in older adults over three seasons, trial shows
A single-dose of the respiratory syncytial virus (RSV) vaccine in older adults showed waning efficacy across three seasons of ...
Managed Healthcare Executive4d
A Win for Adult RSV Vaccination Amid Vaccine Uncertainty, Hesitancy
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
MedPage Today on MSN10d
ACIP Endorses RSV Vaccine for At-Risk Adults 50 and Up
The CDC's Advisory Committee on Immunization Practices (ACIP) voted 14-0, with one abstention, on Wednesday to recommend that ...
Knowridge Science Report5d
Single-dose RSV vaccine protects older adults across three seasons, global study finds
A new global study led by GlaxoSmithKline has found that a single dose of the RSV vaccine Arexvy (RSVPreF3 OA) offers strong ...
US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years
On Wednesday, the Advisory Committee on Immunization Practices (ACIP) voted to expand its recommendation for the use of ...
New Atlas11d
Over 60s get long-term protection against RSV from single shot
A three-year study has found robust evidence that one particular vaccine for respiratory syncytial virus (RSV) offers older ...
Healio13d
RSV triples a person’s risk for death within 1 year, study shows
After decades of fits and starts, scientists finally got the world’s first vaccines against respiratory syncytial virus ...
ACIP Votes to Expand Recommendation for Pfizer’s RSV Vaccine ABRYSVO® to Include Adults Aged 50 to 59 at Increased Risk of Disease
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee ...
Single-dose vaccine demonstrates sustained efficacy against RSV-related lower respiratory tract disease in older adults
Researchers from GlaxoSmithKline have reported that a single dose of the RSV vaccine, Arexvy (RSVPreF3 OA), provides effective protection against respiratory syncytial virus-related lower respiratory ...